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Ͼ10 backcrosses to SHR females. Since conplastic strains are genetically identical except for their mtDNA, any phenotypic differences can be potentially caused by naturally occurring variation in mtDNA. Our previous experiments showed that the SHR-mt BN vs. SHR conplastic strains differ in multiple amino acid substitutions in mtDNA protein coding genes, including a unique mutation in mt-Co1 in BN mtDNA that was associated with reduced mitochondrial cytochrome c oxidase activity and with major metabolic risk factors for Type 2 diabetes including impaired glucose tolerance, reduced skeletal muscle ATP and glycogen concentration, and insulin resistance (8) . In addition, by the analysis of SHR-mt LEW vs. SHR conplastic strains, we obtained evidence that inherited variation in mitochondrial mt-Nd2, mt-Nd4, and mt-Nd5 genes encoding respiratory chain complex I subunits, in the absence of variation in the nuclear genome and other confounding factors, can influence glucose and lipid metabolism (3) . In the current study, we report results obtained by analyses of the SHR-mt F344 vs. SHR conplastic strains. We found multiple differences in F344 vs. SHR mtDNA, including nonsynonymous substitutions in protein coding genes, as well as mutations in tRNA and rRNA genes that were associated with reduced cardiac oxidative phosphorylation system (OXPHOS) enzyme content and activities and cardiac hypertrophy with systolic dysfunction that was independent of blood pressure.
MATERIALS AND METHODS

Animals.
We selectively replaced the mitochondrial genome of a highly inbred strain of spontaneously hypertensive rats (SHR) (SHR/ OlaIpcv strain) with the mitochondrial genome of a highly inbred strain of F344 (F344/Crl) rats to create a novel SHR/OlaIpcv-mt F344 conplastic strain harboring the F344 mitochondrial genome on the SHR nuclear genetic background (SHR-mt F344 ). We derived the conplastic strain using the "supersonic" breeding strategy of Behringer (1) to accelerate the breeding process (6) . In the current experiments, we studied male conplastic rats after 10 -12 generations of backcrossing. Genotype analysis of polymorphic markers distributed at ϳ10 cM intervals across the nuclear genome as previously described (8) confirmed lack of divergence in nuclear DNA between the SHR-mt F344 conplastic strain and the SHR progenitor strain. Thus, there is a very high probability that the conplastic and progenitor strains used in this study are homozygous and identical at any given locus in the nuclear genome. All experiments were performed in agreement with the Animal Protection Law of the Czech Republic and were approved by the Ethics Committee of the Institute of Physiology, Academy of Sciences of the Czech Republic, Prague.
F344 mtDNA sequence analysis. We searched for variants by comparing the published F344 sequence (10) to the published mitochondrial genome sequences (accession # AC000022) of the BN (BN/SsNHsdMCW) and SHR/Ola strains.
Activities and protein content of mitochondrial oxidative phosphorylation enzymes and adenine nucleotide levels. Liver and heart ventricle homogenates (5%, wt/vol) were prepared in STE medium (0.25 M sucrose, 10 mM Tris·HCl, 1 mM EDTA, pH 7.4), 1 g/ml protease inhibitor cocktail (PIC, Sigma P8340), and gastrocnemius muscle homogenates were prepared in KCl medium (150 mM KCl, 2 mM EDTA, 50 mM Tris·HCl, pH 7.4, 1 g/ml PIC) with a motor-driven glass-Teflon homogenizer, filtered through 200 m nylon mesh and frozen at Ϫ80°C.
We used spectrophotometric methods (9, 12) to measure enzyme activities of ferrocytochrome c:oxidoreductase [cytochrome c oxidase (COX), complex IV]; succinate:ferricytochrome c oxidoreductase, succinate cytochrome c reductase (SCCR), complexes II ϩ III; rotenone sensitive NADH:ferricytochrome c oxidoreductase, NADH cytochrome c reductase (NCCR), complexes I ϩ III; and citrate synthase (CS). Enzyme activity results are expressed per mg of homogenate protein.
We used SDS-PAGE and Western blotting of tissue homogenates to measure levels of a panel of mitochondrial respiratory chain proteins using specific antibodies and methods similar to those previously described (4). We have used primary mouse monoclonal antibodies (Abcam) to measure the levels of the 70 kDa subunit of succinate dehydrogenase (ab14715); ␣-subunit of the F 1Fo ATP synthase (ab14748); subunit 4 of cytochrome c oxidase (ab14744); core 2 subunit of ubiquinol:ferricytochrome c oxidoreductase (ab14745); and 39 kDa subunit of NADH:ubiquinone oxidoreductase (ab14713). We quantified the levels of these proteins by detection of infrared fluorescence with anti-mouse Alexa Fluor 680 or IRDye 800-labeled secondary antibodies and an Odyssey Infrared Imaging System (LI-COR Biotechnology, Lincoln, NE). Results are expressed as relative fluorescence units determined per mg of homogenate protein.
Liquid nitrogen snap-frozen samples of skeletal muscle, liver and heart were also processed in for measurement of the content of adenine nucleotides by high pressure liquid chromatography (2) .
Tissue content of mtDNA. We used real-time PCR to measure DNA copy number of mitochondrial genes mt-Co1, mt-Nd4, mt-Atp8, and mt-Cytb relative to the amount of the nuclear gene cytochrome c oxidase, subunit IV, isoform 1 (Cox4i1) as an internal control. For real-time PCR, total DNA was isolated by standard methods and analyzed by real-time PCR testing using QuantiTect SYBR Green reagents (Qiagen, Valencia, CA) on an Opticon continuous fluores- http://physiolgenomics.physiology.org/ cence detector (MJ Research, Waltham, MA) with an annealing temperature of 58°C. Mitochondrial DNA levels were normalized relative to the internal genomic DNA control with relative amounts mtDNA to genomic DNA determined in triplicate. The primers used to amplify mitochondrial genes were: mt-Co1 upstream 5=-gga gca gta ttc gcc atc at, mt-Co1 downstream 5=-cgg ccg taa gtg aga tga at; mt-Cyb upstream 5=-cat cag tca ccc aca tctg c, mt-Cyb downstream 5=-tgg atg gaa tgg gat ttt gt; mt-Nd4 upstream 5=-ctc aca aca cac ccc cta cc, mt-Nd4 downstream 5=-tcc cat aac ccc cta gct tt; mt-Atp8 upstream 5=-tgc cac aac tag aca cat cca, mt-Atp8 downstream 5=-tgt ggg ggt aat gaa aga gg. The primers used to amplify the nuclear gene Cox4i1 were upstream 5=-act acc cct tgc ctg atg tg and downstream 5=-aca gat ctg cgc tca cac ac.
Metabolic phenotypes. After the rats were weaned, we fed the conplastic (n ϭ 10) and control SHR rats (n ϭ 8) standard chow and at 10 wk of age, switched them to a semisynthetic diet (Hope Farms) containing 60% fructose for 2 wk prior to study. In previous studies in the SHR, we have found that administration of a high-fructose diet can increase susceptibility to metabolic disturbances in this strain. At the end of the study, rats in the ad libitum fed state were euthanized with carbon dioxide, and then serum and tissues were collected for final biochemical analyses.
Oral glucose tolerance test. Oral glucose tolerance tests (OGTT) were performed after 2 wk of fructose feeding with a glucose load of 300 mg/100 g body wt after overnight fasting. Blood was drawn from the tail without anesthesia before the glucose load (0 min time point) and at 30, 60, and 120 min thereafter.
Biochemical analyses. Blood glucose levels were measured by the glucose oxidase assay (Erba-Lachema, Brno, Czech Republic) in tail vein blood drawn into 5% trichloroacetic acid and promptly centrifuged. Serum triglyceride concentrations were measured by standard enzymatic methods (Erba-Lachema, Brno, Czech Republic). Nonesterified fatty acids levels were determined with an acyl-CoA oxidasebased colorimetric kit (Roche Diagnostics, Mannheim, Germany). Serum insulin concentrations were determined with the Mercodia Rat Insulin ELISA kit (Mercodia, Uppsala, Sweden).
Muscle triglyceride measurements. For determination of triglycerides, gastrocnemius muscles were powdered under liquid N2 and extracted for 16 h in chloroform-methanol, after which 2% KH2PO4 was added, and the solution was centrifuged. The organic phase was removed and evaporated under N2. The resulting pellet was dissolved in isopropyl alcohol, and triglyceride content was determined by enzymatic assay (Erba-Lachema). 
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Glucose utilization in skeletal muscles. We determined glycogen synthesis in isolated diaphragm muscle by measuring the incorporation of 14 C-U glucose into glycogen. The muscles were attached to a stainless steel frame in situ at in vivo length by special clips and separated from other muscles and tendons and immediately incubated for 2 h in Krebs-Ringer bicarbonate buffer, pH 7.4, gaseous phase 95% O 2 and 5% CO2 that contained 5.5 mM unlabeled glucose, 0.5 Ci/ml of 14 C-U glucose (UVVR, Prague, Czech Republic), and 3 mg/ml bovine serum albumin (Fraction V, Sigma) with or without 250 U/ml insulin. After 2 h incubation, glycogen was extracted and glucose incorporation into glycogen determined.
Glucose utilization in isolated epididymal adipose tissue. Distal parts of epididymal adipose tissue were rapidly dissected and incubated for 2 h in Krebs-Ringer bicarbonate buffer with 5 mmol/l glucose, 0.1 Ci 14 C-U-glucose/ml, and 2% bovine serum albumin, gaseous phase 95% O2 and 5% CO2 in the presence (250 U/ml) or absence of insulin in incubation media. All incubations were performed at 37°C in sealed vials in a shaking water bath. Estimation of 14 C-glucose incorporation into neutral lipids was performed. Adipose tissue was removed from incubation medium, rinsed in saline, and immediately put into chloroform. The pieces of tissue were dissolved with a Teflon pestle homogenizer, methanol was added (chloroformmethanol 2:1), and lipids were extracted at 4°C overnight. The remaining tissue was removed, KH 2PO4 was added, and a clear extract was taken for further analysis. An aliquot was evaporated and reconstituted in scintillation liquid, and the radioactivity measured by scintillation counting. Incremental glucose utilization was calculated as the difference between the insulin stimulated and basal incorporation of glucose into neutral lipids.
Blood pressure measurements. Arterial blood pressure was measured continuously by radiotelemetry in paired experiments between conscious, unrestrained male conplastic rats (n ϭ 8) and SHR controls (n ϭ 8) fed a standard diet starting at the age of 10 wk. All rats were allowed to recover for at least 7 days after surgical implantation of radiotelemetry transducers before the start of blood pressure recordings. Pulsatile pressures were recorded in 5 s bursts every 10 min throughout the day and night, and 24 h averages for systolic arterial blood pressure were calculated for each rat for 1 wk periods. After measuring blood pressure for 2 wk, we gave all rats 1% NaCl for drinking instead of tap water for an additional week of blood pressure measurements to test for effects of the F344 vs. SHR mtDNA on blood pressure salt sensitivity. The results from each rat in the same group were then averaged to obtain the group means.
Echocardiography. Transthoracic echocardiography was performed using the GE Vivid 7 Dimension (GE Vingmed Ultrasound, Horten, Norway) with a 12 MHz linear matrix probe M12-L in 3 mo old animals fed a standard diet. Left ventricular two-dimensional images were obtained in the parasternal long-and short-axis views, and M-mode images were acquired in the long-axis view under isoflurane (2%) inhalation anesthesia (Aerrane, Baxter, SA). The measurements included heart rate (HR), end-diastolic diameter (LVD d), end-systolic diameter (LVDs), diastolic and systolic anterior wall thickness, and diastolic and systolic posterior wall thickness. The main functional parameter, percent fractional shortening (FS) was calculated as follows: FS ϭ 100*(LVDd Ϫ LVDs)/LVDd. At least three measurements were performed in every mode/view and averaged for each rat. After the assessment of the baseline parameters, the maximum response to dobutamine infused into the jugular vein (15 and 30 mg/kg, 4 min each) was obtained. The person evaluating the images was blinded for the experimental group.
Statistical analysis. We used Student's t-test to analyze for differences between group means with statistical significance defined as P Ͻ 0.05. All results are expressed as means Ϯ SE. Values are means Ϯ SE from 9 rats. Levels of AMP, ADP, and ATP are expressed in nmol/g per 100 mg wet wt. Table 1) . Interestingly, three amino acid substitutions occurred exactly at positions of human pathological mutation (mt-Nd2 Ser150Asn, mt-Nd4 ?158Ile, mt-Co2 Val165Ile). Of these the mt-Co2 Val165Ile substitution was identical with human mtDNA mutation associated with maternally inherited deafness and affected the amino acid highly conserved in higher eukaryotes. However, the substitution had only minor effect on the character of this amino acid.
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There were also seven nucleotide substitutions affecting five tRNA genes. Compared with human mtDNA, five of these variations were located very close to described positions of human pathogenic mutations. As is shown in Table 2 , these pathologies include severe diseases like myoclonic epilepsy and ragged red muscle fibers, mitochondrial encephalopathy, cytopathy and myopathy, focal segmental glomerulosclerosis, lactic acidosis, and left ventricular noncompaction (LVNC). The rRNA mtDNA genes displayed also numerous differences between F344 and SHR strains. In the 12S rRNA gene there are only two one-nucleotide changes, but there are multiple sequence differences in the gene for 16S rRNA (Table 3) . Since human and rat 12S and 16S rRNA sequences differ quite a lot, there are only few human pathologies associated with mutations in the rRNA's genes close to the relevant rat sequence where SHR and F344 strain are different. In general, these close mutations in 12S rRNA are in human mostly associated with maternally inherited deafness. In contrast, mutations in 16S rRNA are in humans mostly 
Fig. 3. Oral glucose tolerance test (OGTT).
A: blood glucose levels before and after glucose administration in the SHR progenitor strain (solid line) and the SHR-mt F344 conplastic strain (dashed line). After oral glucose loading, the SHR conplastic strain showed similar glucose levels compared with the SHR progenitor strain. B: serum insulin levels before and after oral glucose administration. Same symbols as for serum glucose results. After oral glucose loading, the SHR-mt F344 conplastic strain showed significantly greater area under the curve for serum insulin levels than the SHR progenitor strain (P Ͻ 0.01). Values are means Ϯ SE from 10 conplastic and 8 control rats. *P Ͻ 0.05; **P Ͻ 0.01. Table 3 .
Mitochondrial OXPHOS enzyme activities. Analysis of mitochondrial OXPHOS system in tissue homogenates revealed a general tendency of a decrease in OXPHOS enzyme-specific activities NCCR, SCCR, COX, and CS in SHR-mt F344 conplastic rats vs. SHR strain (Fig. 1) . The decrease was more pronounced in heart and muscle than in liver.
Mitochondrial OXPHOS enzyme content and mtDNA copy number. Western blot analysis using monoclonal antibodies to selected marker subunits of individual enzyme complexes of mitochondrial respiratory chain further revealed a decrease in several complexes in SHR-mt F344 conplastic rats compared with SHR strain. Based on their specific content per mg protein of tissue homogenate, complexes III and IV were significantly decreased in muscle and complexes I and II in heart, while in liver complex I was decreased and complex II was increased (Fig. 2 ). There were no significant differences in mtDNA copy number (data not shown).
Adenine nucleotide levels. HPLC analysis of tissue content of adenine nucleotides ATP, ADP, and AMP revealed similar relative contribution of ATP and ADP and smaller of AMP to the total nucleotide levels in heart and liver, while in muscle the ATP was most abundant and AMP was very low. Comparison of SHR-mt F344 conplastic rats with SHR strain indicated a small insignificant decrease in ATP/ADP ratio in heart of SHR-mt F344 but not in liver or muscle (Table 4) .
Metabolic phenotypes in SHR-mt F344 conplastic rats. The mean body weight of the conplastic strain was similar to the SHR strain (329 Ϯ 5 vs. 325 Ϯ 4 g). Serum glucose levels were similar between the SHR-mt F344 conplastic and the SHR progenitor strain, while the insulin concentrations tended to be higher in conplastic rats (Table 5 ). During OGTT, conplastic rats showed glucose levels similar to SHR controls. On the other hand, insulin levels were significantly increased in conplastic rats after glucose loading (Fig. 3) , which suggests insulin resistance. Conplastic rats showed significantly reduced nonfasting serum triglyceride levels, while triglyceride levels in liver, skeletal muscle, and heart were similar in conplastic and SHR controls (Table 5 ). Figure 4 shows basal and insulin-stimulated incorporation of radioactively labeled glucose into skeletal muscle glycogen. In the SHR-mt F344 conplastic strain, glucose incorporation into skeletal muscle glycogen was significantly lower than in the SHR progenitor strain both before and after stimulation with insulin. The insulin-induced increase in nonoxidative glucose metabolism was significantly lower in the conplastic rats than in the SHR controls (442 Ϯ 58 vs. 704 Ϯ 129 nmol·g Ϫ1 ·2 h Ϫ1 , P Ͻ 0.05). There were no significant differences in basal or insulin-stimulated incorporation of glucose into adipose tissue lipids between conplastic and control rats (data not shown).
Blood pressures, heart mass, and function. There was no significant difference between SHR-mt F344 conplastic strain and SHR controls in systolic and diastolic blood pressures and HRs (data not shown). The weights of both heart ventricles normalized to body weight were significantly increased in SHR-mt F344 conplastic rats compared with SHR control (Table 6 ). There were no echocardiographically detectable differences in LV dimension and wall thickness between the two groups, except for the increased end-systolic diameter in conplastic rats. In addition, conplastic rats exhibited slight but significant impairment of FS both at baseline and after stimulation with dobutamine compared with the SHR (Table 7) .
DISCUSSION
Recently, we demonstrated in SHR vs. SHR-mt BN and in SHR vs. SHR-mt LEW conplastic rats that naturally occurring variation in mtDNA in the absence of nuclear genome variation Values are means Ϯ SE from 6 rats in each group; *P Ͻ 0.05; †P Ͻ 0.01. HR, heart rate; LVDd, end-diastolic diameter; LVDs, end-systolic diameter; AWTd and AWTs, anterior wall thickness in diastole and systole, respectively; PWTd and PWTs, posterior wall thickness in diastole and systole, respectively; FS, fractional shortening at baseline; FSmax, maximum FS after dobutamine infusion. is associated with selective reduction in content and activity of OXPHOS enzymatic complexes in skeletal muscle and several risk factors for Type 2 diabetes but with no significant differences in blood pressure or cardiac mass (3, 8) . In the present studies, we analyzed phenotypic effects of the mtDNA haplotype of the F344 strain, which is only distantly related to the SHR. Similar to SHR-mt BN and SHR-mt LEW conplastic strains, the SHR-mt F344 conplastic rats exhibited reduced content and activity of OXPHOS protein complexes compared with SHR controls and similar reduction of muscle glycogenesis and increased insulin levels during OGTT (for comparison see Table 8 ). In addition, replacement of mtDNA further caused a mild increase in heart mass in the SHR-mt F344 rats, which was independent of blood pressure because conplastic rats were hypertensive, similar to the SHR. Moreover, SHR-mt F344 conplastic rats exhibited small but significant impairment of cardiac systolic function both at baseline and after the stimulation with dobutamine. These results suggest that the original mtDNA haplotype of the SHR provides a relative protection against LV hypertrophy induced by spontaneous hypertension as well as against resistance of skeletal muscles to insulin action and glucose intolerance, while the mtDNA of F344 origin is less protective. The responsible mechanisms might be linked to reduced content and enzymatic activities of OXPHOS enzymes, as they are the only cellular components containing mtDNA-encoded proteins. Sequence differences between SHR and F344 mtDNA are numerous and include both the protein coding and tRNA genes and may thus affect several components of the OXPHOS system, in accordance with observed changes in the content of different OXPHOS complexes. Several differences in SHR/F344 mtDNA genes encoding OXPHOS subunits affected amino acids whose mutations were found to be pathological in humans (http://www.mitomap.org), and several other changes were closely apposed to established human pathological mutations. The conplastic model of SHR convincingly indicates that phenotypical changes at organ and organism levels are direct consequences of the changes in mtDNA-OXPHOS, but the further biochemical links remain to be elucidated. ATP production and mitochondrially generated reactive oxygen species (ROS) represent primary metabolites produced by OXPHOS system. We were unable to find significant differences in adenine nucleotide levels by HPLC analysis, which reflects the total cellular nucleotides but does not allow for detection of in situ changes in different subcellular compartment.
Recently, Kumarasamy et al. (5) reported analyses of reciprocal conplastic strains derived from SHR and SS (salt sensitive) strains. While no significant differences were observed in the SHR-mt SS conplastic strain with mtDNA of the SS/Jr (salt sensitive) origin in heart weight, blood pressure, treadmill aerobic capacity, ROS production, or mtDNA copy number compared with SHR progenitor strain, the reciprocal SS-mt SHR conplastic strain with mtDNA of SHR origin on the SS genetic background exhibited significantly increased aerobic capacity and survival time compared with SS progenitor strain. These results suggest that SHR mtDNA is protective compared with the SS mtDNA, which is consistent with our findings in SHR conplastic strains in which mtDNA of BN, LEW, and F344 origin was associated with reduced activities of OXPHOS complexes and metabolic disturbances compared with SHR progenitor strain.
In addition, Sethumadhavan et al. (11) reported that the T2DN-mt FHH conplastic strain, which carries mtDNA of Fawn Hooded Hypertensive origin on a genetic background of the T2DN/Mcwi strain, a model of diabetic nephropathy closely related to Goto-Kakizaki strain (7), exhibited significantly decreased complex I and complex IV activities, reduced ATP levels in heart tissue, and increased left ventricular diastolic and systolic dimensions but no significant differences in left ventricular mass or left ventricular systolic function compared with the T2DN-mt Wistar strain (11) . However, these findings are difficult to compare to results of the current study because of differences between mtDNA haplotypes and genetic backgrounds of SHR vs. T2DN strains, when complex interactions between nuclear and mitochondrial genomes can affect mitochondrial function and cardiometabolic traits.
In summary, we have found that inherited variation in mitochondrial genes encoding respiratory chain complexes can influence mitochondrial function, glucose tolerance, and sensitivity of skeletal muscle to insulin action as well as cardiac remodeling and function. These results should serve to motivate future studies of the role of naturally occurring variation of mtDNA in the pathogenesis of cardiometabolic traits in humans. 
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